These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15755267)

  • 1. Optimizing cardiovascular and chemopreventive benefits of aspirin: what role for the proton-pump inhibitors?
    Scheiman J
    Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():7-8, 21-4. PubMed ID: 15755267
    [No Abstract]   [Full Text] [Related]  

  • 2. The prevalence of risk factors for gastrointestinal complications and use of gastroprotection among persons hospitalized for cardiovascular disease.
    Targownik LE; Al-Mamfud A
    Aliment Pharmacol Ther; 2006 Mar; 23(6):743-9. PubMed ID: 16556176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recommendations for treatment with nonsteroidal anti-inflammatory drugs].
    Bolten WW
    MMW Fortschr Med; 2005 Aug; 147(31-32):24-7. PubMed ID: 16128192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What price pain relief?
    Hochman JS; Shah NR
    Circulation; 2006 Jun; 113(25):2868-70. PubMed ID: 16785335
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.
    Harewood G
    N Engl J Med; 1999 Oct; 341(18):1398; author reply 1398-9. PubMed ID: 10577093
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of aspirin-induced gastroduodenal damage: H. pylori infection eradication versus proton pump inhibitors or both.
    Lanas A
    Dig Liver Dis; 2004 Oct; 36(10):655-7. PubMed ID: 15506662
    [No Abstract]   [Full Text] [Related]  

  • 7. Daily low-dose aspirin: beware of GI bleeding.
    Johns Hopkins Med Lett Health After 50; 2012 Mar; 24(1):6. PubMed ID: 22493823
    [No Abstract]   [Full Text] [Related]  

  • 8. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
    Lanas A; Ferrandez A
    Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemopreventive agents in colorectal cancer].
    Benamouzig R; Chaussade S
    Rev Prat; 2003 Dec; 53(20):2213-4. PubMed ID: 15018072
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of low-dose aspirin: emphasis on outliers undermines the credibility of the conclusions.
    Graham DY
    Aliment Pharmacol Ther; 2007 Feb; 25(3):345-6; author reply 346-7. PubMed ID: 17217449
    [No Abstract]   [Full Text] [Related]  

  • 11. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL; Cryer B; Amer F; Hunt B
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal anti-inflammatory drugs, aspirin, and gastrointestinal prophylaxis: an ounce of prevention.
    Scheiman JM
    Rev Gastroenterol Disord; 2005; 5 Suppl 2():39-49. PubMed ID: 16369226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendation with serious adverse effects].
    Ruminski W; Jensen K; Kringelbach TM; Vang O; Bouchelouche PN; Munck LK
    Ugeskr Laeger; 2006 Feb; 168(9):928; author reply 928-9. PubMed ID: 16513066
    [No Abstract]   [Full Text] [Related]  

  • 14. Underutilization of gastroprotective strategies in aspirin users at increased risk of upper gastrointestinal complications.
    Targownik LE; Metge CJ; Leung S
    Aliment Pharmacol Ther; 2008 Jul; 28(1):88-96. PubMed ID: 18410563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey.
    Chey WD; Eswaren S; Howden CW; Inadomi JM; Fendrick AM; Scheiman JM
    Aliment Pharmacol Ther; 2006 Mar; 23(5):655-68. PubMed ID: 16480405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: gastrointestinal bleeding with low-dose aspirin - what's the risk?
    Laine L
    Aliment Pharmacol Ther; 2006 Sep; 24(6):897-908. PubMed ID: 16948802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin: the balance between benefits and harms. Preface.
    Lanas A
    Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):97-9. PubMed ID: 22542148
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment.
    Lanas A; Scheiman J
    Curr Med Res Opin; 2007 Jan; 23(1):163-73. PubMed ID: 17257477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks.
    Rostom A; Moayyedi P; Hunt R;
    Aliment Pharmacol Ther; 2009 Mar; 29(5):481-96. PubMed ID: 19053986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.